Beijing hanmi pharm co ltd has a total of 45 patent applications. It decreased the IP activity by 36.0%. Its first patent ever was published in 2017. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SANKT PETERBURGSKAYA OBSCHESTV, BIOTHERAPIES INC and HALE GEOFFREY.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Brazil | 3 | |
#6 | Canada | 3 | |
#7 | Mexico | 3 | |
#8 | Philippines | 3 | |
#9 | Chile | 2 | |
#10 | Colombia | 2 | |
#11 | Dominican Republic | 2 | |
#12 | Ecuador | 2 | |
#13 | Israel | 2 | |
#14 | Peru | 2 | |
#15 | Singapore | 2 | |
#16 | Tunisia | 2 | |
#17 | EPO (European Patent Office) | 1 | |
#18 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Liu Jiawang | 32 |
#2 | Yang Yaping | 32 |
#3 | Song Nanmeng | 32 |
#4 | Jin Mengxie | 31 |
#5 | Zhang Hongjuan | 23 |
#6 | Yang Yang | 14 |
#7 | Yang Dongge | 12 |
#8 | Yaping Yang | 8 |
#9 | Mengxie Jin | 8 |
#10 | Nanmeng Song | 8 |
Publication | Filing date | Title |
---|---|---|
WO2019034153A1 | Chemical compound, pharmaceutical composition thereof, and use and application thereof | |
AU2017328309A1 | Antibody specifically binding to PD-1 and functional fragment thereof | |
US2019256588A1 | Antibody specifically binding to il-17a and functional fragment thereof |